The long cytoplasmic carboxyl terminus of the prostaglandin E2 receptor EP4 subtype is essential for agonist-induced desensitization

Molecular Pharmacology

Volumn 51, Issue 2, 1997, Pages 343-349

  Bastepe, Murat ^a   Ashby, Barrie ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; COMPLEMENTARY DNA; CYCLIC AMP; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; RECEPTOR SUBTYPE; RESTRICTION ENDONUCLEASE; SERINE; THREONINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; CYTOPLASM; ERYTHROLEUKEMIA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION;

EID: 0031024509     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.51.2.343     Document Type: Article

References (48)

1. Campbell, W. B., and P. V. Halushka. Lipid-derived autocoids, in Pharmacological Basis of Therapeutics (A. G. Gilman, J. G. Hardman, L. L. Limbird, P. B. Molinoff, and R. W. Ruddon, eds.). McGraw-Hill, Health Professions Division, New York, 601-616 (1996).
2. Coleman, R. A., I. Kennedy, P. P. A. Humphrey, K. Bunce, and P. Lumley. Neurotransmitter, autocoid receptors, and prostanoid receptors, in Comprehensive Medicinal Chemistry (C. Hansch, P. G. Sammes, J. B. Taylor, J. C. Emmett, P. D. Kennewell, and C. A. Ramsden, eds.). Vol. 3. Pergamon Press, Oxford, 643-714 (1990).
3. Coleman, R. A., S. P. Grix, S. A. Head, J. B. Louttit, A. Mallett, and R. L. Sheldrick. A novel inhibitory prostanoid receptor in piglet saphenous vein. Prostaglandins 47:151-168 (1994).
4. 3 receptors: evidence of three variants with differing carboxyl termini. Br. J. Pharmacol. 112:377-385 (1994).
5. 2 receptor transduce both intracellular calcium and cAMP signals. Biochemistry 33:14496-14502 (1994).
6. 3 prostanoid receptor. FEBS Lett. 338:170-174 (1994).
7. 2. Eur. J. Biochem. 228:23-30 (1995).
8. 3 subtype generated by alternative messenger RNA splicing: multiple second messenger systems and tissue-specific distributions. Mol. Pharmacol. 48:869-879 (1995).
9. 3 subtype: different COOH-terminal domains determine sensitivity to agonist-induced desensitization. J. Biol. Chem. 268:9517-9521 (1993).
10. 3 subtype different in agonist-independent constitutive activity. J. Biol. Chem. 271:1857-1860 (1996).
11. 3γ isoform, with mostly full constitutive Gi activity and agonist-dependent Gs activity. FEBS Lett. 386:165-168 (1996).
12. 3 subtype with different C-terminal tail coupling to both stimulation and inhibition of adenylate cyclase. Eur. J. Biochem. 217:313-318 (1993).
13. 3 receptor with different carboxyl-terminal domains: identical ligand binding properties and different coupling properties with Gi proteins. J. Biol. Chem. 268:2712-2718 (1993).
14. Ashby, B. Kinetic evidence indicating separate stimulatory and inhibitory prostaglandin receptors on platelet membranes. J. Cyclic Nucleotide Protein Phosphorylation Res. 11:291-300 (1986).
15. Ashby, B. Cyclic AMP turnover in response to prostaglandins in intact platelets: evidence for separate stimulatory and inhibitory prostaglandin receptors. Second Messengers Phosphoproteins 12:45-57 (1988).
16. Ashby, B. Model of prostaglandin-regulated cyclic AMP metabolism in intact platelets: examination of time-dependent effects on adenylate cyclase and phosphodiesterase activities. Mol. Pharmacol. 36:866-873 (1989).
17. Ashby, B. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets. Mol. Pharmacol. 38:46-53 (1990).
18. Lohse, M. J. Molecular mechanisms of membrane receptor desensitization. Biochim. Biophys. Acta 1179:171-188 (1993).
19. 2 subtype. J. Biol. Chem. 268:7759-7762 (1993).
20. 2. Biochem. Biophys. Res. Commun. 197:263-270 (1993).
21. 2 subtype. J. Biol. Chem. 269:11873-11877 (1994).
22. 2 subtype from human erythroleukemia cells (abstract). Can. J. Physiol. Pharmacol. 72 (Suppl. 1):542 (1994).
23. 2 subtype. Mol. Pharmacol. 46:213-220 (1994).
24. 4 subtype. FEBS Lett. 364:339-341 (1995).
25. Roth, N. S., P. T. Campbell, M. G. Caron, R. J. Lefkowitz, and M. J. Lohse. Comparative rates of desensitization of β-adrenergic receptors by the β-adrenergic receptor kinase and the cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. USA 88:6201-6204 (1991).
26. Hausdorff, W. P., P. T. Campbell, J. Ostrowski, S. S. Yu, M. G. Caron, and R J. Lefkowitz. A small region of the β-adrenergic receptor is selectively involved in its rapid regulation. Proc. Natl. Acad. Sci. USA 88:2979-2983 (1991).
27. Takano, T., Z. Honda, C. Sakanaka, T. Izumi, K. Kameyama, K. Haga, T. K. Haga, K. Kurokawa, and T. Shimizu. Role of cytoplasmic tail phosphorylation sites of platelet-activating factor receptor in agonist-induced desensitization. J. Biol. Chem. 269:22453-22458 (1994).
28. Lattion, A. L., D. Diviani, and S. Cotecchia. Truncation of the receptor carboxyl terminus impairs agonist-dependent phosphorylation and desensitization of the α1B-adrenergic receptor. J. Biol. Chem. 269:22887-22893 (1994).
29. Sanchez-Yague, J., M. C. Rodriguez, D. L. Segaloff, and M. Ascoli. Truncation of the cytoplasmic tail of the lutropin/choriogonadotropin receptor prevents agonist-induced uncoupling. J. Biol. Chem. 267:7217-7220 (1992).
30. Zhu, X., T. Gudermann, M. Birnbaumer, and L. Birnbaumer. A luteinizing hormone receptor with a severely truncated cytoplasmic tail (LHR-ct628) desensitizes to the same degree as the full-length receptor. J. Biol. Chem. 268:1723-1728 (1993).
31. Ohyama, K., Y. Yamano, S. Chaki, T. Kondo, and T. Inagami. Domains for G-protein coupling in angiotensin II receptor type I: studies by site-directed mutagenesis. Biochem. Biophys. Res. Commun. 189:677-683 (1992).
32. Samama, P., S. Cotecchia, T. Costa, and R. J. Lefkowitz. A mutation-induced activated state of the β2-adrenergic receptor: extending the ternary complex model. J. Biol. Chem. 268:4625-4636 (1993).
33. Chomczynski, P., and N. Sacchi. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:156-159 (1987).
34. Feinberg, A. P., and B. Vogelstein. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13 (1983).
35. Feinberg, A. P., and B. Vogelstein. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity (addendum). Anal. Biochem. 137:266-267 (1984).
36. Benton, W. D., and R. W. Davis. Screening Agt recombinant clones by hybridization to single plaques in situ. Science (Washington D. C.) 196: 180-182 (1977).
37. Sanger, F., S. Nicklen, and A. R. Coulson. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467 (1977).
38. Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, and M. Danielsen. Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84: 7413-7417 (1987).
39. Salomon, Y. Adenylate cyclase assay. Adv. Cyclic Nucleotide Res. 10:35-55 (1979).
40. Sedmak, J. J., and S. E. Grossberg. A rapid, sensitive, and versatile assay for protein using Coomassie brilliant blue G250. Anal. Biochem. 79:544-552 (1977).
41. 3 subtype from human erythroleukaemia cells. Biochem. J. 298:263-267 (1994).
42. McPherson, G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput. Prog. Biomed. 17:107-113 (1983).
43. 3H]palmitic acid. J. Biol. Chem. 259:5054-5057 (1984).
44. Ovchinnikov, Y. A., N. G. Abdulaev, and A. S. Bogachuk. Two adjacent cysteine residues in the C-terminal cytoplasmic fragment of bovine rhodopsin are palmitoylated. FEBS Lett. 230:1-5 (1988).
45. 341 in the carboxyl tail leads to an uncoupled nonpalmitoylated form of the receptor. J. Biol. Chem. 264:7564-7569 (1989).
46. O'Dowd, B. F., M. Hnatowich, J. W. Regan, W. M. Leader, M. G. Caron, and R. J. Lefkowitz. Site-directed mutagenesis of the cytoplasmic domains of the human β2-adrenergic receptor: localization of regions involved in G protein-receptor coupling. J. Biol. Chem. 263:15985-15992 (1988).
47. Benovic, J. L., R. H. Strasser, M. G. Caron, and R. J. Lefkowitz. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc. Natl. Acad. Sci. USA 83:2797-2801 (1986).
48. Inglese, J., N. J. Freedman, W. J. Koch, and R. J. Lefkowitz. Structure and mechanism of the G protein-coupled receptor kinases. J. Biol. Chem. 268:23735-23738 (1993).